TISSUE & FFPE COHORT COLLECTIONS
Breast cancer tissue microarrays & FFPE blocks
Compare breast cancer arrays by receptor profile, tissue composition and available clinical records. Collections include ER-positive disease, triple-negative breast cancer, and selected primary and matched metastatic tissue. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Breast cancer arrays (27)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
Breast Cancer (non-TNBC) (e) TMA (TA4349)
- Approx. cores
- 30
- Approx. donors
- 10
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Breast cancer array with histopath data & matched plasma (TA4459)
- Approx. cores
- 25
- Approx. donors
- 25
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Breast cancer pre and post treatment, includes ER+, ER-,Her2(+), Her2(-), TNBC; donor matched & unmatched samples with follow up & PD-L1, CD3 & CD8 IHC data (TA3113)
- Approx. cores
- 55
- Approx. donors
- 55
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
Breast cancer pre and post treatment, includes ER+, ER-,Her2(+), Her2(-), TNBC; donor matched & unmatched samples with follow up & PD-L1, CD3 & CD8 IHC data (TA3114)
- Approx. cores
- 6
- Approx. donors
- 6
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
Breast cancer primary & matched nodal & distant mets with survival data (TA3165)
- Approx. cores
- 52
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Breast cancers ER+ (relapsed) with follow up information (Edited version TA1621) (TA4438)
- Approx. cores
- 95
- Approx. donors
- 51
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
herceptin eligible breast cancer TMA with histopath data (TMA9311)
- Approx. cores
- 100
- Approx. donors
- 50
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
IO Multi tumor array 1 of a set of 6 TMAs : Breast cancer ER+, Her2+, TNBC, NSCLC(SCC), NSCLC(ADC), Small Cell Lung Cancer (SCLC) with histopath data, 1x1mm core each from tumor & invasive edge (TA3124)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
IO Multi tumor array 1 of a set of 6 TMAs : Breast cancer ER+, Her2+, TNBC, NSCLC(SCC), NSCLC(ADC), Small Cell Lung Cancer (SCLC) with histopath data, 1x1mm core each from tumor & invasive edge (TA4439)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array 1 of a set of 4 TMAs : Breast cancer ER+, Her2+, TNBC, CRC, NSCLC, Prostate ADC with histopath data (TA2995)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array comprising breast, bladder(uc), ovarian, lung, prostate, melanoma, RCC , head & neck SCC, CRC, pancreatic ADC with histopath data (TA4340)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising cores with high immune infiltrates from Pancreatic, Melanoma, Breast, HCC & CRC. TMA2 of a set of 2 TMAs, histopath data (TA4313)
- Approx. cores
- 120
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4341)
- Approx. cores
- 45
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Normal (non-malignant) breast, colon, lymph node, lung, prostate & breast cancer, CRC, prostate ADC, NSCLC & DLBCL, 2mm (TA2942)
- Approx. cores
- 30
- Approx. donors
- 30
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array 120 cores total, 1mm core diameter – (same as previous TA4380) (TA4388)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array, 2mm core diameter, TMA1 of a set of 2 TMAs, histopath data (TA3117)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
TNBC (III/IV) with ER,PR,Her2 & histopath data (TA2210)
- Approx. cores
- 24
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
TNBC post treatment TMA with follow up data (TA4434)
- Approx. cores
- 50
- Approx. donors
- 25
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
TNBC post treatment TMA with follow up data (TA4487)
- Approx. cores
- 44
- Approx. donors
- 22
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
TNBC primary & matched mets with follow up data (new version of TA3067) (TA4505)
- Approx. cores
- 32
- Approx. donors
- 16
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
TNBC primary & matched mets with follow up data (TA3067)
- Approx. cores
- 36
- Approx. donors
- 18
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
TNBC primary & Mets TMA with follow up data (TA4435)
- Approx. cores
- 88
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
TNBC with ER,PR,Her2 & survival data (TA2270)
- Approx. cores
- 51
- Approx. donors
- 51
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
TNBC with ER,PR,Her2, CA9 & histopath data (TA2273)
- Approx. cores
- 49
- Approx. donors
- 49
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Triple negative breast cancer (TNBC) with histopath data (TA3163)
- Approx. cores
- 60
- Approx. donors
- 59
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Triple negative breast cancer (TNBC) with histopath data with PPIB scores (TA3164)
- Approx. cores
- 38
- Approx. donors
- 37
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
tumor & invasive edge cores/donor, breast cancer, NSCLC, HD (TA3108)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Breast cancer FFPE blocks for your study
Breast cancer and TNBC cohorts with receptor, treatment, metastatic or matched-plasma information.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Breast cancer FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #26
Breast Cancer (non-TNBC) with histopath data
Cohort #27
Breast cancer pre and post treatment, includes ER+, ER-, Her2(+), Her2(-), TNBC; donor unmatched samples with follow up data
Cohort #28
Breast cancer primary & matched nodal & distant mets with survival data
Cohort #180
Breast cancer with matched double spun plasma
Cohort #30
Breast cancers ER+ (relapsed) with follow up information
Cohort #31
TNBC (III/IV) with ER,PR,Her2 & histopath data
Cohort #32
TNBC post treatment with follow up data
Cohort #33
TNBC primary & Mets with follow up data
Cohort #35
TNBC with ER,PR,Her2 & survival data
Cohort #36
TNBC with ER,PR,Her2, CA9 & histopath data
Cohort #37
Triple negative breast cancer (TNBC) with histopath data
Cohort #38
Herceptin eligible breast cancer with histopath data
Breast cancer · Patient profile
TNBC across all stages, including metastatic disease
Breast cancer · Patient profile
Breast cancer stages I–III
Breast cancer · Patient profile
Before or after CDK4/6 inhibitor treatment
Breast cancer · Patient profile
BRCA1/2- or PALB2-mutated, HR-positive / HER2-negative advanced disease
Breast cancer · Patient profile
ER-positive / HER2-negative advanced disease
Breast cancer · Patient profile
HER2-negative, BRCA-mutated neoadjuvant cohorts
Breast cancer · Patient profile
HER2-positive metastatic disease
SELECTING YOUR ARRAY
Select the breast cancer context your study needs
Receptor profile, treatment setting and donor matching describe different aspects of an array. Check each against your study requirements.













